Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
培养转化糖生物学家:糖科学培训与临床教育的结合
基本信息
- 批准号:10418674
- 负责人:
- 金额:$ 95.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAppointmentBloodBostonClinicalClinical MedicineDana-Farber Cancer InstituteDevelopmentDiseaseEducationEducational workshopEnsureFacultyFundingGeneral HospitalsGlycobiologyGoalsGrowthHeart DiseasesHospitalsHuman BiologyIndividualInstructionIsraelKnowledgeLaboratoriesLungMassachusettsMedicalMedical centerMentorsNCI Scholars ProgramPediatric HospitalsPostdoctoral FellowPrincipal InvestigatorProgram DevelopmentResearchResearch PersonnelResourcesScientistSleepTeaching HospitalsTechnical ExpertiseTrainingTranslational ResearchUniversitiesWomanbasecareercareer developmentclinical caredesignexperienceforginghuman diseasemedical schoolsmultidisciplinaryprogramsskills
项目摘要
ABSTRACT
Currently there are very few individuals that can place clinical medicine within the framework of glycoscience,
and vice versa. The key to bridging this translational chasm is to support the development of scientists with
requisite interdisciplinary knowledge and experience by providing training in glycosciences concomitantly with
education in human biology, altogether framed by an appreciation of human diseases and clinical urgency.
This application addresses this need by pioneering a multi-disciplinary career development program in
glycosciences within the context of clinical medicine that will create a cadre of “Translational Glycobiologists,”
individuals who will perform glycoscience-based inquiry inspired by medical necessity. Fundamentally, this
goal will be accomplished by equipping Program Scholars with the requisite intellectual background and the
necessary lab skills in the glycosciences, together with an in-depth appreciation of clinical issues. To this
end, we will build partnerships between experienced glycoscience researchers and clinicians within the
Harvard teaching hospitals to nurture Program Scholar training in glycoscience principles and technical skills
integrated with clinical knowledge and practice. The combination of Principal Investigators dedicated to this
goal (Drs. Sackstein, Chaikof, and Cummings), together with the assembled faculty and the extraordinary
hospital resources, makes this program ideal for career development in Translational Glycobiology. By
design, the program capitalizes on the long tradition of translational research within the Brigham & Women’s
Hospital, the Beth Israel Deaconess Medical Center, the Massachusetts General Hospital, the Boston
Children’s Hospital, and the Dana-Farber Cancer Institute, as well as within the greater Harvard Medical
School and Harvard University. Through coursework and seminars, Program Scholars will gain glycoscience
knowledge with concomitant development of technical knowledge and skills in both primary laboratory settings
and workshops. To ensure development across both scientific and clinical spectrums, each Program Scholar
will be jointly mentored by a Research Mentor for lab-based project-oriented glycoscientific training and a
Clinical Mentor for hospital-based clinical education. In addition, each Program Scholar will have a dedicated
Career Mentor that will further support the Scholar transition towards career independence. Scholar
appointments will be for two years (maximum three years), and we anticipate a total of ten Scholars over the
duration of the funding period, with four Scholars being junior faculty clinicians and six Scholars being senior
post-doctoral fellows. We believe that this unique combination of glycoscience education, laboratory
instruction, clinical exposures, and mentoring will launch a cadre of biomedical investigators that will
accelerate the growth of glycoscience, and, more importantly, will create needed glycoscience-based
breakthroughs that will transform clinical care for disorders of heart, lung, blood, and sleep, and for many,
many other diseases.
抽象的
目前能够将临床医学置于糖科学框架内的人很少,
反之亦然,弥合这一转化鸿沟的关键是支持科学家的发展。
通过提供糖科学培训,同时提供必要的跨学科知识和经验
人类生物学教育,完全以对人类疾病和临床紧迫性的认识为框架。
该应用程序通过在以下领域开创了多学科职业发展计划来满足这一需求
临床医学背景下的糖科学将创建一支“转化糖生物学家”骨干队伍
从根本上说,受医学必要性启发,将进行基于糖科学的调查的人。
通过为项目学者提供必要的知识背景和
糖科学方面必要的实验室技能,以及对临床问题的深入了解。
最后,我们将在经验丰富的糖科学研究人员和新人之间建立伙伴关系
哈佛大学教学医院培养糖科学原理和技术技能方面的项目学者培训
与临床知识和实践相结合的主要研究者致力于此。
目标(萨克斯坦博士、柴科夫和卡明斯),以及聚集的教师和非凡的
医院资源,使该计划成为转化糖生物学职业发展的理想选择。
设计中,该项目充分利用了布莱根妇女医院转化研究的悠久传统
医院、贝斯以色列女执事医疗中心、马萨诸塞州综合医院、波士顿
儿童医院、丹娜法伯癌症研究所以及哈佛医学院
通过课程和研讨会,项目学者将获得糖科学。
在初级实验室环境中同时发展技术知识和技能的知识
为了确保科学和临床领域的发展,每位项目学者
将由研究导师共同指导进行基于实验室的项目导向的糖科学培训和
此外,每个项目学者都会有一名专门的临床导师。
职业导师将进一步支持学者向职业独立过渡。
任命期限为两年(最多三年),我们预计在此期间共有十名学者
资助期限,其中四名学者为初级教员,六名学者为高级教员
我们相信,这种糖科学教育、实验室的独特结合。
指导、临床暴露和指导将培养一支生物医学研究人员骨干队伍,他们将
加速糖科学的发展,更重要的是,将创造所需的基于糖科学的
突破将改变心脏、肺、血液和睡眠疾病的临床护理,并且对许多人来说,
许多其他疾病。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The impact of ABO and RhD blood types on Babesia microti infection.
ABO 和 RhD 血型对田鼠巴贝虫感染的影响。
- DOI:
- 发表时间:2023-01
- 期刊:
- 影响因子:3.8
- 作者:Jajosky, Ryan Philip;O'Bryan, Jane;Spichler;Jajosky, Philip G;Krause, Peter J;Tonnetti, Laura
- 通讯作者:Tonnetti, Laura
Plasmodium knowlesi (Pk) Malaria: A Review & Proposal of Therapeutically Rational Exchange (T-REX) of Pk-Resistant Red Blood Cells.
诺氏疟原虫 (Pk) 疟疾:回顾
- DOI:
- 发表时间:2023-10-20
- 期刊:
- 影响因子:0
- 作者:Jajosky, Ryan Philip;Wu, Shang;Jajosky, Philip G;Stowell, Sean R
- 通讯作者:Stowell, Sean R
O-glycan recognition and function in mice and human cancers.
O-聚糖在小鼠和人类癌症中的识别和功能。
- DOI:10.1042/bcj20180103
- 发表时间:2020-04-29
- 期刊:
- 影响因子:0
- 作者:G. Cervoni;Jane J. Cheng;K. Stackhouse;Jamie Heimburg;R. Cummings
- 通讯作者:R. Cummings
Identification of α1,2-fucosylated signaling and adhesion molecules in head and neck squamous cell carcinoma.
头颈鳞状细胞癌中α1,2-岩藻糖基化信号和粘附分子的鉴定。
- DOI:
- 发表时间:2022-04-21
- 期刊:
- 影响因子:4.3
- 作者:Montesino, Brittany;Steenackers, Agata;Lozano, Juan M;Young, Geoffrey D;Hu, Nan;Sackstein, Robert;Chandler, Kevin Brown
- 通讯作者:Chandler, Kevin Brown
Multidimensional separation and analysis of alpha-1-acid glycoprotein N-glycopeptides using high-field asymmetric waveform ion mobility spectrometry (FAIMS) and nano-liquid chromatography tandem mass spectrometry.
使用高场不对称波形离子迁移谱 (FAIMS) 和纳米液相色谱串联质谱法对 α-1-酸性糖蛋白 N-糖肽进行多维分离和分析。
- DOI:
- 发表时间:2023-01
- 期刊:
- 影响因子:4.3
- 作者:Chandler, Kevin Brown;Marrero Roche, Daniel E;Sackstein, Robert
- 通讯作者:Sackstein, Robert
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD D CUMMINGS其他文献
RICHARD D CUMMINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD D CUMMINGS', 18)}}的其他基金
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10672258 - 财政年份:2021
- 资助金额:
$ 95.85万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10454419 - 财政年份:2021
- 资助金额:
$ 95.85万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10293635 - 财政年份:2021
- 资助金额:
$ 95.85万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10442455 - 财政年份:2020
- 资助金额:
$ 95.85万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10023486 - 财政年份:2020
- 资助金额:
$ 95.85万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10442455 - 财政年份:2020
- 资助金额:
$ 95.85万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10642767 - 财政年份:2020
- 资助金额:
$ 95.85万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10205105 - 财政年份:2020
- 资助金额:
$ 95.85万 - 项目类别:
Integrating microbial glycan arrays with genomic sequences to study host microbe interactions
将微生物聚糖阵列与基因组序列整合以研究宿主微生物相互作用
- 批准号:
9814477 - 财政年份:2019
- 资助金额:
$ 95.85万 - 项目类别:
Integrating microbial glycan arrays with genomic sequences to study host microbe interactions
将微生物聚糖阵列与基因组序列整合以研究宿主微生物相互作用
- 批准号:
10290100 - 财政年份:2019
- 资助金额:
$ 95.85万 - 项目类别:
相似国自然基金
面向集卡预约环境的港口集疏运道路作业计划与管控方法
- 批准号:52372303
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
面向一站式预约的门诊患者多检查动态调度优化研究
- 批准号:72371200
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
考虑患者等待时长的医疗系统预约调度研究:基于近似动态规划的方法
- 批准号:72272027
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
基于集卡预约扰动致因解构的港口集疏运通道空间尺度优化研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
数据驱动下港口集卡预约系统的预约配额方案优化与失约车辆再预约策略研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Children’s National Stimulating Access to Research in Residency (CNStARR) Program (NHLBI)
儿童国家激励住院医师研究机会 (CNStARR) 计划 (NHLBI)
- 批准号:
10593715 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Mentorship in patient-oriented research on behavioral and social determinants of cardiometabolic health
指导以患者为中心的心脏代谢健康行为和社会决定因素的研究
- 批准号:
10589326 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Automated system to improve compliance to diabetic retinopathy screening
自动化系统可提高糖尿病视网膜病变筛查的依从性
- 批准号:
10697609 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Automated system to improve compliance to diabetic retinopathy screening
自动化系统可提高糖尿病视网膜病变筛查的依从性
- 批准号:
10697609 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别:
Spatialomics and quantitative MRI of ischemic injury in a piglet model of Legg-Calve-Perthes disease
Legg-Calve-Perthes 病仔猪模型缺血性损伤的空间组学和定量 MRI
- 批准号:
10806492 - 财政年份:2023
- 资助金额:
$ 95.85万 - 项目类别: